The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ
(−)-2′-deoxy-3′-thiacytidine (3TC) † † 3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K. has been shown to be a potent, selective inhibitor of HIV replication in vitro, which requires phosphorylation to its 5′-triphosphate for antiviral activity....
Gespeichert in:
Veröffentlicht in: | Biochemical pharmacology 1995-09, Vol.50 (7), p.1043-1051 |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 1051 |
---|---|
container_issue | 7 |
container_start_page | 1043 |
container_title | Biochemical pharmacology |
container_volume | 50 |
creator | Gray, Norman M. Marr, Clara L.P. Penn, Charles R. Cameron, Janet M. Bethell, Richard C. |
description | (−)-2′-deoxy-3′-thiacytidine (3TC)
†
†
3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K.
has been shown to be a potent, selective inhibitor of HIV replication
in vitro, which requires phosphorylation to its 5′-triphosphate for antiviral activity. The intracellular concentration of 3TC 5′-triphosphate in phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBL) shows a linear dependence on the extracellular concentration of 3TC up to an extracellular 3TC concentration of 10 μM. At this extracellular concentration of 3TC, the resulting intracellular concentration of 3TC 5′-triphosphate is 5 μM. This value is similar to the inhibition constant (
K
i) values for the competitive inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and human DNA polymerases (10–16 μM) by 3TC 5′-triphosphate. Since the concentration of 3TC producing 90% inhibition (IC
90) of HIV replication in PBLs has been reported to be 76 nM, the antiviral activity of 3TC requires intracellular concentrations of 3TC 5′-triphosphate, which would result in very little inhibition of reverse transcriptase if its sole mode of action was competitive inhibition. This apparent discrepency may be explained by the ability of 3TC 5′-triphosphate to act as a substrate for reverse transcriptase. Primer extension assays have shown that 3TC 5′-triphosphate is a substrate for HIV-1 reverse transcriptase and DNA polymerase γ, resulting in the incorporation of 3TC 5′-monophosphate into DNA. In the case of DNA polymerase γ, the product of this reaction (i.e. double-stranded DNA with 3TC 5′-monophosphate incorporated at the 3′-terminus of the primer strand) is also a substrate for the 3′-5′ exonuclease activity of this enzyme. This may explain the low levels of mitochondrial toxicity observed with 3TC. |
doi_str_mv | 10.1016/0006-2952(95)96620-A |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_17054132</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>000629529596620A</els_id><sourcerecordid>17054132</sourcerecordid><originalsourceid>FETCH-LOGICAL-c417t-252c1ae9a84b92c26fb93a09499cca6a3e7316db9a285e5d0bddfc8ccdcb32de3</originalsourceid><addsrcrecordid>eNp9UU2O0zAUjhBoKAM3AMkLhNpFwD-JE2-QqvIzI41gU9hajv2iGiVxsN0R2bFkzVHgBFyAQ8xJcNqqSxaW_fz9vKf3ZdlTgl8STPgrjDHPqSjpUpQrwTnF-fpetiB1xdI3r-9nizPlYfYohC9zWXNykV1UZVVyjhfZn-0OkB2iVxq6bt8pj8adC-n4qVPRugG5Fi3vfvxc5fTu-6_cgPs25Wx-xp1VeorW2AHQkm03K6QGg-LBUTs_On92SCgqZ1HvBnfsoOKhs0NvPqxRM6Gr6885QR5uwQdAaaIhaG_HqFI1--72vRoO5NF1Uw9-Bv7-fpw9aFUX4Mnpvsw-vXu73VzlNx_fX2_WN7kuSBVzWlJNFAhVF42gmvK2EUxhUQihteKKQcUIN41QtC6hNLgxptW11kY3jBpgl9mLo-_o3dc9hCh7G-alqQHcPkhS4bIgjCZicSRq70Lw0MrR2175SRIs5-TknIOcY5GilIfk5DrJnp38900P5iw6RZXw5ydcBa26Nu1H23Cm0VoUnLNEe32kQdrFrQUvg7YwaDDWg47SOPv_Of4BegW7mg</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17054132</pqid></control><display><type>article</type><title>The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ</title><source>MEDLINE</source><source>Access via ScienceDirect (Elsevier)</source><creator>Gray, Norman M. ; Marr, Clara L.P. ; Penn, Charles R. ; Cameron, Janet M. ; Bethell, Richard C.</creator><creatorcontrib>Gray, Norman M. ; Marr, Clara L.P. ; Penn, Charles R. ; Cameron, Janet M. ; Bethell, Richard C.</creatorcontrib><description>(−)-2′-deoxy-3′-thiacytidine (3TC)
†
†
3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K.
has been shown to be a potent, selective inhibitor of HIV replication
in vitro, which requires phosphorylation to its 5′-triphosphate for antiviral activity. The intracellular concentration of 3TC 5′-triphosphate in phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBL) shows a linear dependence on the extracellular concentration of 3TC up to an extracellular 3TC concentration of 10 μM. At this extracellular concentration of 3TC, the resulting intracellular concentration of 3TC 5′-triphosphate is 5 μM. This value is similar to the inhibition constant (
K
i) values for the competitive inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and human DNA polymerases (10–16 μM) by 3TC 5′-triphosphate. Since the concentration of 3TC producing 90% inhibition (IC
90) of HIV replication in PBLs has been reported to be 76 nM, the antiviral activity of 3TC requires intracellular concentrations of 3TC 5′-triphosphate, which would result in very little inhibition of reverse transcriptase if its sole mode of action was competitive inhibition. This apparent discrepency may be explained by the ability of 3TC 5′-triphosphate to act as a substrate for reverse transcriptase. Primer extension assays have shown that 3TC 5′-triphosphate is a substrate for HIV-1 reverse transcriptase and DNA polymerase γ, resulting in the incorporation of 3TC 5′-monophosphate into DNA. In the case of DNA polymerase γ, the product of this reaction (i.e. double-stranded DNA with 3TC 5′-monophosphate incorporated at the 3′-terminus of the primer strand) is also a substrate for the 3′-5′ exonuclease activity of this enzyme. This may explain the low levels of mitochondrial toxicity observed with 3TC.</description><identifier>ISSN: 0006-2952</identifier><identifier>EISSN: 1873-2968</identifier><identifier>DOI: 10.1016/0006-2952(95)96620-A</identifier><identifier>PMID: 7575660</identifier><identifier>CODEN: BCPCA6</identifier><language>eng</language><publisher>New York, NY: Elsevier Inc</publisher><subject>3TC ; 3TC 5′-triphosphate ; Antibiotics. Antiinfectious agents. Antiparasitic agents ; Antiviral agents ; Base Sequence ; Biological and medical sciences ; chain termination ; Deoxycytidine Monophosphate - analogs & derivatives ; Deoxycytidine Monophosphate - metabolism ; DNA - metabolism ; DNA Polymerase III - metabolism ; DNA polymerase γ ; HeLa Cells ; HIV Reverse Transcriptase ; HIV-1 reverse transcriptase ; human immunodeficiency virus 1 ; Humans ; intracellular phosphorylation ; Kinetics ; Lamivudine ; Lymphocytes - drug effects ; Lymphocytes - metabolism ; Medical sciences ; Molecular Sequence Data ; Pharmacology. Drug treatments ; Phosphorylation ; Phytohemagglutinins ; Reverse Transcriptase Inhibitors - metabolism ; RNA-Directed DNA Polymerase - metabolism ; Stereoisomerism ; Zalcitabine - analogs & derivatives ; Zalcitabine - metabolism ; Zalcitabine - pharmacology</subject><ispartof>Biochemical pharmacology, 1995-09, Vol.50 (7), p.1043-1051</ispartof><rights>1995</rights><rights>1996 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c417t-252c1ae9a84b92c26fb93a09499cca6a3e7316db9a285e5d0bddfc8ccdcb32de3</citedby><cites>FETCH-LOGICAL-c417t-252c1ae9a84b92c26fb93a09499cca6a3e7316db9a285e5d0bddfc8ccdcb32de3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/0006-2952(95)96620-A$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>315,782,786,3552,27931,27932,46002</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2894663$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/7575660$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Gray, Norman M.</creatorcontrib><creatorcontrib>Marr, Clara L.P.</creatorcontrib><creatorcontrib>Penn, Charles R.</creatorcontrib><creatorcontrib>Cameron, Janet M.</creatorcontrib><creatorcontrib>Bethell, Richard C.</creatorcontrib><title>The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ</title><title>Biochemical pharmacology</title><addtitle>Biochem Pharmacol</addtitle><description>(−)-2′-deoxy-3′-thiacytidine (3TC)
†
†
3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K.
has been shown to be a potent, selective inhibitor of HIV replication
in vitro, which requires phosphorylation to its 5′-triphosphate for antiviral activity. The intracellular concentration of 3TC 5′-triphosphate in phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBL) shows a linear dependence on the extracellular concentration of 3TC up to an extracellular 3TC concentration of 10 μM. At this extracellular concentration of 3TC, the resulting intracellular concentration of 3TC 5′-triphosphate is 5 μM. This value is similar to the inhibition constant (
K
i) values for the competitive inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and human DNA polymerases (10–16 μM) by 3TC 5′-triphosphate. Since the concentration of 3TC producing 90% inhibition (IC
90) of HIV replication in PBLs has been reported to be 76 nM, the antiviral activity of 3TC requires intracellular concentrations of 3TC 5′-triphosphate, which would result in very little inhibition of reverse transcriptase if its sole mode of action was competitive inhibition. This apparent discrepency may be explained by the ability of 3TC 5′-triphosphate to act as a substrate for reverse transcriptase. Primer extension assays have shown that 3TC 5′-triphosphate is a substrate for HIV-1 reverse transcriptase and DNA polymerase γ, resulting in the incorporation of 3TC 5′-monophosphate into DNA. In the case of DNA polymerase γ, the product of this reaction (i.e. double-stranded DNA with 3TC 5′-monophosphate incorporated at the 3′-terminus of the primer strand) is also a substrate for the 3′-5′ exonuclease activity of this enzyme. This may explain the low levels of mitochondrial toxicity observed with 3TC.</description><subject>3TC</subject><subject>3TC 5′-triphosphate</subject><subject>Antibiotics. Antiinfectious agents. Antiparasitic agents</subject><subject>Antiviral agents</subject><subject>Base Sequence</subject><subject>Biological and medical sciences</subject><subject>chain termination</subject><subject>Deoxycytidine Monophosphate - analogs & derivatives</subject><subject>Deoxycytidine Monophosphate - metabolism</subject><subject>DNA - metabolism</subject><subject>DNA Polymerase III - metabolism</subject><subject>DNA polymerase γ</subject><subject>HeLa Cells</subject><subject>HIV Reverse Transcriptase</subject><subject>HIV-1 reverse transcriptase</subject><subject>human immunodeficiency virus 1</subject><subject>Humans</subject><subject>intracellular phosphorylation</subject><subject>Kinetics</subject><subject>Lamivudine</subject><subject>Lymphocytes - drug effects</subject><subject>Lymphocytes - metabolism</subject><subject>Medical sciences</subject><subject>Molecular Sequence Data</subject><subject>Pharmacology. Drug treatments</subject><subject>Phosphorylation</subject><subject>Phytohemagglutinins</subject><subject>Reverse Transcriptase Inhibitors - metabolism</subject><subject>RNA-Directed DNA Polymerase - metabolism</subject><subject>Stereoisomerism</subject><subject>Zalcitabine - analogs & derivatives</subject><subject>Zalcitabine - metabolism</subject><subject>Zalcitabine - pharmacology</subject><issn>0006-2952</issn><issn>1873-2968</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1995</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9UU2O0zAUjhBoKAM3AMkLhNpFwD-JE2-QqvIzI41gU9hajv2iGiVxsN0R2bFkzVHgBFyAQ8xJcNqqSxaW_fz9vKf3ZdlTgl8STPgrjDHPqSjpUpQrwTnF-fpetiB1xdI3r-9nizPlYfYohC9zWXNykV1UZVVyjhfZn-0OkB2iVxq6bt8pj8adC-n4qVPRugG5Fi3vfvxc5fTu-6_cgPs25Wx-xp1VeorW2AHQkm03K6QGg-LBUTs_On92SCgqZ1HvBnfsoOKhs0NvPqxRM6Gr6885QR5uwQdAaaIhaG_HqFI1--72vRoO5NF1Uw9-Bv7-fpw9aFUX4Mnpvsw-vXu73VzlNx_fX2_WN7kuSBVzWlJNFAhVF42gmvK2EUxhUQihteKKQcUIN41QtC6hNLgxptW11kY3jBpgl9mLo-_o3dc9hCh7G-alqQHcPkhS4bIgjCZicSRq70Lw0MrR2175SRIs5-TknIOcY5GilIfk5DrJnp38900P5iw6RZXw5ydcBa26Nu1H23Cm0VoUnLNEe32kQdrFrQUvg7YwaDDWg47SOPv_Of4BegW7mg</recordid><startdate>19950928</startdate><enddate>19950928</enddate><creator>Gray, Norman M.</creator><creator>Marr, Clara L.P.</creator><creator>Penn, Charles R.</creator><creator>Cameron, Janet M.</creator><creator>Bethell, Richard C.</creator><general>Elsevier Inc</general><general>Elsevier Science</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TM</scope><scope>7U9</scope><scope>H94</scope></search><sort><creationdate>19950928</creationdate><title>The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ</title><author>Gray, Norman M. ; Marr, Clara L.P. ; Penn, Charles R. ; Cameron, Janet M. ; Bethell, Richard C.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c417t-252c1ae9a84b92c26fb93a09499cca6a3e7316db9a285e5d0bddfc8ccdcb32de3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1995</creationdate><topic>3TC</topic><topic>3TC 5′-triphosphate</topic><topic>Antibiotics. Antiinfectious agents. Antiparasitic agents</topic><topic>Antiviral agents</topic><topic>Base Sequence</topic><topic>Biological and medical sciences</topic><topic>chain termination</topic><topic>Deoxycytidine Monophosphate - analogs & derivatives</topic><topic>Deoxycytidine Monophosphate - metabolism</topic><topic>DNA - metabolism</topic><topic>DNA Polymerase III - metabolism</topic><topic>DNA polymerase γ</topic><topic>HeLa Cells</topic><topic>HIV Reverse Transcriptase</topic><topic>HIV-1 reverse transcriptase</topic><topic>human immunodeficiency virus 1</topic><topic>Humans</topic><topic>intracellular phosphorylation</topic><topic>Kinetics</topic><topic>Lamivudine</topic><topic>Lymphocytes - drug effects</topic><topic>Lymphocytes - metabolism</topic><topic>Medical sciences</topic><topic>Molecular Sequence Data</topic><topic>Pharmacology. Drug treatments</topic><topic>Phosphorylation</topic><topic>Phytohemagglutinins</topic><topic>Reverse Transcriptase Inhibitors - metabolism</topic><topic>RNA-Directed DNA Polymerase - metabolism</topic><topic>Stereoisomerism</topic><topic>Zalcitabine - analogs & derivatives</topic><topic>Zalcitabine - metabolism</topic><topic>Zalcitabine - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Gray, Norman M.</creatorcontrib><creatorcontrib>Marr, Clara L.P.</creatorcontrib><creatorcontrib>Penn, Charles R.</creatorcontrib><creatorcontrib>Cameron, Janet M.</creatorcontrib><creatorcontrib>Bethell, Richard C.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Nucleic Acids Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Biochemical pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Gray, Norman M.</au><au>Marr, Clara L.P.</au><au>Penn, Charles R.</au><au>Cameron, Janet M.</au><au>Bethell, Richard C.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ</atitle><jtitle>Biochemical pharmacology</jtitle><addtitle>Biochem Pharmacol</addtitle><date>1995-09-28</date><risdate>1995</risdate><volume>50</volume><issue>7</issue><spage>1043</spage><epage>1051</epage><pages>1043-1051</pages><issn>0006-2952</issn><eissn>1873-2968</eissn><coden>BCPCA6</coden><abstract>(−)-2′-deoxy-3′-thiacytidine (3TC)
†
†
3TC is a trademark of Glaxo Group Ltd., Glaxo House, Greenford Road, Greenford, Middlesex UB6 OHE, U.K.
has been shown to be a potent, selective inhibitor of HIV replication
in vitro, which requires phosphorylation to its 5′-triphosphate for antiviral activity. The intracellular concentration of 3TC 5′-triphosphate in phytohaemagglutinin (PHA)-stimulated peripheral blood lymphocytes (PBL) shows a linear dependence on the extracellular concentration of 3TC up to an extracellular 3TC concentration of 10 μM. At this extracellular concentration of 3TC, the resulting intracellular concentration of 3TC 5′-triphosphate is 5 μM. This value is similar to the inhibition constant (
K
i) values for the competitive inhibition of human immunodeficiency virus type 1 (HIV-1) reverse transcriptase and human DNA polymerases (10–16 μM) by 3TC 5′-triphosphate. Since the concentration of 3TC producing 90% inhibition (IC
90) of HIV replication in PBLs has been reported to be 76 nM, the antiviral activity of 3TC requires intracellular concentrations of 3TC 5′-triphosphate, which would result in very little inhibition of reverse transcriptase if its sole mode of action was competitive inhibition. This apparent discrepency may be explained by the ability of 3TC 5′-triphosphate to act as a substrate for reverse transcriptase. Primer extension assays have shown that 3TC 5′-triphosphate is a substrate for HIV-1 reverse transcriptase and DNA polymerase γ, resulting in the incorporation of 3TC 5′-monophosphate into DNA. In the case of DNA polymerase γ, the product of this reaction (i.e. double-stranded DNA with 3TC 5′-monophosphate incorporated at the 3′-terminus of the primer strand) is also a substrate for the 3′-5′ exonuclease activity of this enzyme. This may explain the low levels of mitochondrial toxicity observed with 3TC.</abstract><cop>New York, NY</cop><pub>Elsevier Inc</pub><pmid>7575660</pmid><doi>10.1016/0006-2952(95)96620-A</doi><tpages>9</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0006-2952 |
ispartof | Biochemical pharmacology, 1995-09, Vol.50 (7), p.1043-1051 |
issn | 0006-2952 1873-2968 |
language | eng |
recordid | cdi_proquest_miscellaneous_17054132 |
source | MEDLINE; Access via ScienceDirect (Elsevier) |
subjects | 3TC 3TC 5′-triphosphate Antibiotics. Antiinfectious agents. Antiparasitic agents Antiviral agents Base Sequence Biological and medical sciences chain termination Deoxycytidine Monophosphate - analogs & derivatives Deoxycytidine Monophosphate - metabolism DNA - metabolism DNA Polymerase III - metabolism DNA polymerase γ HeLa Cells HIV Reverse Transcriptase HIV-1 reverse transcriptase human immunodeficiency virus 1 Humans intracellular phosphorylation Kinetics Lamivudine Lymphocytes - drug effects Lymphocytes - metabolism Medical sciences Molecular Sequence Data Pharmacology. Drug treatments Phosphorylation Phytohemagglutinins Reverse Transcriptase Inhibitors - metabolism RNA-Directed DNA Polymerase - metabolism Stereoisomerism Zalcitabine - analogs & derivatives Zalcitabine - metabolism Zalcitabine - pharmacology |
title | The intracellular phosphorylation of (−)-2′-deoxy-3′-thiacytidine (3TC) and the incorporation of 3TC 5′-monophosphate into DNA by HIV-1 reverse transcriptase and human DNA polymerase γ |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-04T10%3A34%3A48IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=The%20intracellular%20phosphorylation%20of%20(%E2%88%92)-2%E2%80%B2-deoxy-3%E2%80%B2-thiacytidine%20(3TC)%20and%20the%20incorporation%20of%203TC%205%E2%80%B2-monophosphate%20into%20DNA%20by%20HIV-1%20reverse%20transcriptase%20and%20human%20DNA%20polymerase%20%CE%B3&rft.jtitle=Biochemical%20pharmacology&rft.au=Gray,%20Norman%20M.&rft.date=1995-09-28&rft.volume=50&rft.issue=7&rft.spage=1043&rft.epage=1051&rft.pages=1043-1051&rft.issn=0006-2952&rft.eissn=1873-2968&rft.coden=BCPCA6&rft_id=info:doi/10.1016/0006-2952(95)96620-A&rft_dat=%3Cproquest_cross%3E17054132%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17054132&rft_id=info:pmid/7575660&rft_els_id=000629529596620A&rfr_iscdi=true |